Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1342717 [patent_doc_number] => 06582701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Equine Fc epsilon receptor alpha chain proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/515311 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23957 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582701.pdf [firstpage_image] =>[orig_patent_app_number] => 09515311 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/515311 		Equine Fc epsilon receptor alpha chain proteins and uses thereof Feb 28, 2000 Issued
Array ( [id] => 1349736 [patent_doc_number] => 06579969 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Goodpasture antigen binding protein' [patent_app_type] => B1 [patent_app_number] => 09/512563 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 48833 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579969.pdf [firstpage_image] =>[orig_patent_app_number] => 09512563 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/512563 		Goodpasture antigen binding protein Feb 23, 2000 Issued
Array ( [id] => 1136411 [patent_doc_number] => 06780416 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Bee venom polypeptides and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/506978 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10666 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780416.pdf [firstpage_image] =>[orig_patent_app_number] => 09506978 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/506978 		Bee venom polypeptides and methods of use thereof Feb 17, 2000 Issued
Array ( [id] => 401349 [patent_doc_number] => 07291714 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-11-06 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/503387 [patent_app_country] => US [patent_app_date] => 2000-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 35 [patent_no_of_words] => 52683 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291714.pdf [firstpage_image] =>[orig_patent_app_number] => 09503387 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/503387 		Glycoprotein VI and uses thereof Feb 13, 2000 Issued
09/494096 Methods and reagents for decreasing clinical reactions to allergy Jan 27, 2000 Abandoned
Array ( [id] => 7964511 [patent_doc_number] => 06680171 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis' [patent_app_type] => B1 [patent_app_number] => 09/489155 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 27627 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680171.pdf [firstpage_image] =>[orig_patent_app_number] => 09489155 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/489155 		I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis Jan 20, 2000 Issued
Array ( [id] => 1030825 [patent_doc_number] => 06878375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'HA-1 antigen' [patent_app_type] => utility [patent_app_number] => 09/489760 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12423 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878375.pdf [firstpage_image] =>[orig_patent_app_number] => 09489760 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/489760 		HA-1 antigen Jan 20, 2000 Issued
09/403870 METHODS FOR DETECTING AUTOIMMUNE PATHOLOGIES Jan 12, 2000 Abandoned
09/478668 METHODS AND REAGENTS FOR DECREASING CLINICAL REACTION TO ALLERGY Jan 5, 2000 Abandoned
09/471224 Calorie restriction mimetics Dec 22, 1999 Abandoned
09/402275 STRL33, A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION Dec 21, 1999 Abandoned
Array ( [id] => 1592753 [patent_doc_number] => 06383484 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Antibodies to truncated VEGF-D and thereof' [patent_app_type] => B1 [patent_app_number] => 09/469186 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8571 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383484.pdf [firstpage_image] =>[orig_patent_app_number] => 09469186 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/469186 		Antibodies to truncated VEGF-D and thereof Dec 20, 1999 Issued
09/402273 ALLERGEN FORMULATION Dec 12, 1999 Abandoned
09/455294 PEPTIDE ANTIGENS Dec 5, 1999 Abandoned
09/331980 ANTIBODIES SPECIFICALLY RECOGNISING A NITROSYLATED PROTEIN, METHOD OF PREPARATION, THERAPEUTIC AND DIAGNOSTIC USE Nov 25, 1999 Abandoned
09/444794 INHIBITORS FOR USE IN HEMOSTASIS AND IMMUNE FUNCTION Nov 21, 1999 Abandoned
Array ( [id] => 1448906 [patent_doc_number] => 06455041 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Immunogenic epitopes of the human zona pellucida protein (ZP1)' [patent_app_type] => B1 [patent_app_number] => 09/441502 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 11443 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455041.pdf [firstpage_image] =>[orig_patent_app_number] => 09441502 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/441502 		Immunogenic epitopes of the human zona pellucida protein (ZP1) Nov 16, 1999 Issued
09/440514 NOVEL TRIGGERING RECEPTOR INVOLVED IN NATURAL CYTOTOXICITY MEDIATED BY HUMAN NATURAL KILLER CELLS AND ANTIBODIES THAT IDENTIFY THE SAME Nov 14, 1999 Abandoned
Array ( [id] => 1423543 [patent_doc_number] => 06503736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Antibodies to crosslinkers and methods for using the same' [patent_app_type] => B1 [patent_app_number] => 09/438895 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3455 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503736.pdf [firstpage_image] =>[orig_patent_app_number] => 09438895 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/438895 		Antibodies to crosslinkers and methods for using the same Nov 11, 1999 Issued
09/419694 HUMAN APOPTOSIS INHIBITING PROTEIN Oct 13, 1999 Abandoned
Menu